Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
In the nineties, Sikiric licensed the compound to a Croatian company called Pliva, which sought a treatment for ulcerative colitis
This documentation helps troubleshoot if research results seem unexpected
Dig Dis Sci 54:20702083 Sikiric P, Seiwerth S, Rucman R, Turkovic B, Rokotov D, Brcic L, Sever M, Klicek R, Radic B, Drmic D, Ilic S, Kolenc D, Aralica G, Stupnisek M, Suran J, Barisic I, Dzidic S, Vrcic H, Sebecic B (2014) Stable gastric pentadecapeptide BPC 157-NO-system relation
The Dose Question BPC-157 demonstrates an unusual dose-response curve, with effectiveness across an extremely wide range
Discovered in 2017, the 5-amino-1MQ serves as a means to block the activity of the nicotinamide-N-methyltransferase (NNMT) enzyme
US$ 25.42
US$ 24.43
US$ 21.23
US$ 28.44
US$ 29.82
US$ 20.75
US$ 20.30
